Dihydroergotamine and Ibritumomab Intravenous
Determining the interaction of Dihydroergotamine and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection)
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine-Ibritumomab Tiuxetan
- Dihydroergotamine-Ibrutinib
- Dihydroergotamine-Ibrutinib Capsules
- Dihydroergotamine-Ibrutinib Tablets
- Dihydroergotamine-Ibu
- Dihydroergotamine-IBU Tablets
- Ibritumomab Intravenous-Dihydroergotamine injection
- Ibritumomab Intravenous-Dihydroergotamine Mesylate
- Ibritumomab Intravenous-Dihydroergotamine nasal
- Ibritumomab Intravenous-Dihydroergotamine Nasal Spray
- Ibritumomab Intravenous-Dilacor XR
- Ibritumomab Intravenous-Dilantin